[DPHARMA] YoY Quarter Result on 31-Dec-2019 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
13-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Dec-2019 [#4]
Profit Trend
QoQ- -19.02%
YoY- -16.26%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 151,960 145,444 134,086 137,755 115,634 112,253 74,033 12.72%
PBT 15,347 17,128 20,471 13,939 17,658 12,825 6,299 15.99%
Tax 1,814 -1,412 -4,278 -1,906 -3,289 -1,057 2,532 -5.40%
NP 17,161 15,716 16,193 12,033 14,369 11,768 8,831 11.70%
-
NP to SH 17,161 15,716 16,193 12,033 14,369 11,870 8,428 12.57%
-
Tax Rate -11.82% 8.24% 20.90% 13.67% 18.63% 8.24% -40.20% -
Total Cost 134,799 129,728 117,893 125,722 101,265 100,485 65,202 12.86%
-
Net Worth 657,045 621,564 642,484 525,364 483,173 479,809 454,703 6.32%
Dividend
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Div 17,140 16,951 42,361 34,114 26,475 16,737 11,158 7.41%
Div Payout % 99.88% 107.86% 261.60% 283.51% 184.25% 141.01% 132.40% -
Equity
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Net Worth 657,045 621,564 642,484 525,364 483,173 479,809 454,703 6.32%
NOSH 952,239 941,765 706,026 684,383 661,881 278,959 278,959 22.69%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 11.29% 10.81% 12.08% 8.74% 12.43% 10.48% 11.93% -
ROE 2.61% 2.53% 2.52% 2.29% 2.97% 2.47% 1.85% -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 15.96 15.44 18.99 20.19 17.47 40.24 26.54 -8.12%
EPS 1.80 1.67 2.29 1.76 2.17 4.22 3.41 -10.09%
DPS 1.80 1.80 6.00 5.00 4.00 6.00 4.00 -12.45%
NAPS 0.69 0.66 0.91 0.77 0.73 1.72 1.63 -13.34%
Adjusted Per Share Value based on latest NOSH - 684,383
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 15.80 15.12 13.94 14.32 12.02 11.67 7.70 12.72%
EPS 1.78 1.63 1.68 1.25 1.49 1.23 0.88 12.45%
DPS 1.78 1.76 4.40 3.55 2.75 1.74 1.16 7.39%
NAPS 0.683 0.6462 0.6679 0.5461 0.5023 0.4988 0.4727 6.32%
Price Multiplier on Financial Quarter End Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 -
Price 1.61 1.68 3.38 1.42 0.95 2.53 1.98 -
P/RPS 10.09 10.88 17.80 7.03 5.44 6.29 7.46 5.15%
P/EPS 89.34 100.67 147.37 80.52 43.76 59.46 65.54 5.29%
EY 1.12 0.99 0.68 1.24 2.29 1.68 1.53 -5.06%
DY 1.12 1.07 1.78 3.52 4.21 2.37 2.02 -9.35%
P/NAPS 2.33 2.55 3.71 1.84 1.30 1.47 1.21 11.53%
Price Multiplier on Announcement Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 23/02/23 15/02/22 22/02/21 13/02/20 18/02/19 28/02/18 24/02/17 -
Price 1.65 1.60 3.42 1.64 1.03 2.97 2.23 -
P/RPS 10.34 10.36 18.01 8.12 5.90 7.38 8.40 3.52%
P/EPS 91.56 95.88 149.11 92.99 47.45 69.80 73.81 3.65%
EY 1.09 1.04 0.67 1.08 2.11 1.43 1.35 -3.50%
DY 1.09 1.13 1.75 3.05 3.88 2.02 1.79 -7.93%
P/NAPS 2.39 2.42 3.76 2.13 1.41 1.73 1.37 9.71%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment